Cargando…
Infection and infectivity: Utility of rapid antigen tests for the diagnosis of COVID-19
Detection of SARS-CoV-2 proteins is commercially available in the form of lateral-flow rapid antigen test for the point-of-care diagnosis of COVID-19. This platform has been validated for symptomatic and asymptomatic individuals, for diagnosis or screening, and as part of single or sequential diagno...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedad Española de Quimioterapia
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683002/ https://www.ncbi.nlm.nih.gov/pubmed/34598426 http://dx.doi.org/10.37201/req/s01.14.2021 |